As the cost-of-living crisis intensifies, people from all walks of life are struggling. ABC Your Say asked ordinary ...
A look at the demographic drivers of Saturday’s state election result shows it’s one that should scare both (traditional) ...
A new study has found that a prebiotic fibre supplement reduced pain, improved grip strength, and lowered pain sensitivity in people with knee ...
Pharmaceutical Technology on MSN
FDA accepts Sun Pharma’s Ilumya sBLA for psoriatic arthritis
Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.
More Australian children and young adults are suffering from arthritis symptoms, according to the Juvenile Arthritis ...
Discover strategies to manage fatigue from rheumatoid arthritis. Learn tips for controlling symptoms, boosting energy, and improving daily life effectively.
Bimekizumab was superior to risankizumab at 16 weeks for improving PsA symptoms in a head-to-head clinical trial.
First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon ...
TODAY Show anchor Al Roker posted a video of himself last week doing a sled push. Sled pushes involve pushing a sled—a piece of gym equipment—across the floor. This exercise works the whole body, and ...
If the sBLA is approved, expansion into psoriatic arthritis would build on the established clinical experience of ILUMYA as an IL-23 inhibitor for moderate-to-severe ...
Sun Pharmaceutical Industries Limited has announced that the US Food and Drug Administration (USFDA) has accepted for review its supplemental Biologics License Application (sBLA) ...
Osteoarthritis is one of the most common causes of long-term pain and disability. In Australia alone, more than two million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results